JP2008063281A - Liquid preparation composition - Google Patents
Liquid preparation composition Download PDFInfo
- Publication number
- JP2008063281A JP2008063281A JP2006243468A JP2006243468A JP2008063281A JP 2008063281 A JP2008063281 A JP 2008063281A JP 2006243468 A JP2006243468 A JP 2006243468A JP 2006243468 A JP2006243468 A JP 2006243468A JP 2008063281 A JP2008063281 A JP 2008063281A
- Authority
- JP
- Japan
- Prior art keywords
- caffeine
- brain
- yellow
- test
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 239000007788 liquid Substances 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 7
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 46
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229960001948 caffeine Drugs 0.000 claims abstract description 23
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 23
- 241000234280 Liliaceae Species 0.000 claims description 8
- 239000003623 enhancer Substances 0.000 claims 1
- 210000004556 brain Anatomy 0.000 abstract description 12
- 238000004364 calculation method Methods 0.000 abstract description 6
- 230000006872 improvement Effects 0.000 abstract description 6
- 241000037813 Polygonatum falcatum Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 17
- 235000013361 beverage Nutrition 0.000 description 12
- 238000000605 extraction Methods 0.000 description 12
- 230000035622 drinking Effects 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 244000269722 Thea sinensis Species 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 230000004044 response Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 208000019914 Mental Fatigue Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 240000003444 Paullinia cupana Species 0.000 description 2
- 235000000556 Paullinia cupana Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003930 cognitive ability Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000912433 Paulinia Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- -1 ethyl acetate Chemical compound 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、脳の意識レベルをリラックス状態に導くことにより、ヒトの演算能力の向上効果をもたらす液剤組成物に関する。
The present invention relates to a liquid composition that brings about an effect of improving human computing ability by leading a brain consciousness level to a relaxed state.
カフェインは、茶葉中に含まれる中枢性興奮作用を有する成分として知られ、旧来より、覚醒効果を期待した各種飲料が発売されている。近年では、その中枢性作用に着目し、カルボニックアンヒドラーゼ活性化因子との併用や(特許文献1参照)、茶葉中に含まれる成分テアニンとの併用(特許文献2参照)によって、ヒトの認知能力や注意集中力を高める技術が開示されてきた。また、同様に茶葉中に含まれる成分エピカテキンとの組合わせでは、精神疲労に対する緩和効果をもたらす技術が開示されている(特許文献3参照)。そして、カフェインと茶葉成分を組合せた上で、さらに、特定のアミノ酸を併用することにより、精神疲労の緩和と集中力の維持増強がもたらされることが明らかにされている(特許文献4参照)。しかし、これらの技術は、疲労状態にある精神機能を緩和・軽減することで、認知能力や注意集中力の回復改善効果を示すに留まり、数学的演算行為など、健常人におけるより高度な思考活動に対する能力向上効果を示すまでには至っていない。 Caffeine is known as a component having a central excitatory action contained in tea leaves, and various drinks that have been expected to have an arousal effect have been on the market for a long time. In recent years, focusing on its central action, human cognition has been achieved through the combined use with carbonic anhydrase activator (see Patent Document 1) and with theanine component contained in tea leaves (see Patent Document 2). Techniques have been disclosed to increase ability and attention concentration. Similarly, in combination with the component epicatechin contained in tea leaves, a technique for providing a relaxation effect on mental fatigue has been disclosed (see Patent Document 3). And after combining caffeine and a tea leaf component, it is clarified that the combined use of a specific amino acid brings about relaxation of mental fatigue and maintenance of concentration (see Patent Document 4). . However, these technologies only improve recovery of cognitive ability and attention concentration by relieving and reducing mental functions in a fatigued state, and more advanced thinking activities such as mathematical operations in healthy people. It has not yet been shown to improve the ability to
本発明者らは、数学的演算行為など、脳における高度な思考活動の能力向上を図ることを目的とした。すなわち、従来のカフェインと茶葉成分の組合わせによって導かれる疲労状態における精神疲労の回復改善効果だけでは不十分であると考えた。本発明は、健常人において、より積極的に脳意識レベルをリラックス状態に導き、単なる認知能力や注意集中力の回復改善に留まらない、演算能力の向上効果に優れた液剤組成物を提供することを目的とする。
The present inventors have aimed to improve the ability of advanced thinking activities in the brain, such as mathematical operations. That is, it was considered that the mental fatigue recovery improvement effect in a fatigue state derived from a combination of conventional caffeine and tea leaf components is not sufficient. The present invention provides a liquid composition excellent in the effect of improving the computing ability, not only improving the recovery of cognitive ability and attention concentration, but also leading the brain consciousness level to a relaxed state more actively in a healthy person. With the goal.
本発明者らは、健常人において脳活動をリラックス状態に導き、より高度な思考活動の能力を向上せしめる液剤組成物の研究を鋭意進めてきた。その結果、カフェインにユリ科植物由来の黄精抽出物を加えることにより、演算能力を効果的に向上せしめる液剤組成物を見出し、本発明を完成するに至った。 The inventors of the present invention have been diligently researching a liquid composition that leads brain activity to a relaxed state in a healthy person and improves the ability of more advanced thinking activities. As a result, by adding a yellow extract derived from a lily family plant to caffeine, the present inventors have found a liquid composition that can effectively improve the computing ability, and have completed the present invention.
本発明は、カフェインおよびユリ科植物ナルコユリ由来の黄精抽出物を合わせて含有することを特徴とする液剤組成物の提供に関する。
The present invention relates to the provision of a liquid composition comprising a combination of caffeine and a yellow extract derived from a lily family plant Narcoli.
本発明によれば、液剤組成物において、カフェインにユリ科植物ナルコユリ由来の黄精抽出物を配合することにより、健常人の脳意識レベルをリラックス状態に導き、あわせて演算能力の向上を図ることが可能となる。
According to the present invention, in the liquid composition, the brain consciousness level of a healthy person is brought into a relaxed state by combining caffeine with a yellow spirit extract derived from the lily family plant Narcoli, and at the same time, the computing ability is improved. Is possible.
本発明に用いられる黄精抽出物の出発原料となる黄精は、ユリ科(Liliaceae)の植物ナルコユリ(Polygonatum falcatum)の根茎であり、おもに中国本土の長江流域以北の諸省または自治区(黒龍江、吉林、遼寧、河北、山東、江蘇、河南、山西、陝西、内蒙古)を産地とする。 Polygonati Rhizoma as a starting material of Polygonati Rhizoma extract used in the present invention is the rhizome of a plant Narukoyuri the Liliaceae (Liliaceae) (Polygonatum f alcatum) , mainly Chinese mainland various Ministry or autonomous regions of Yangtze basin north (Heilongjiang , Jilin, Liaoning, Hebei, Shandong, Jiangsu, Henan, Shanxi, Shaanxi, Inner Mongolia).
黄精は、乾燥粉砕したものをそのまま使用することができるが、溶媒等を用いて抽出した抽出物を用いることもできる。抽出の際は、生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが望ましい。抽出は、抽出溶媒に浸漬する方法や超臨界流体等を用いた抽出方法など一般的な方法で行うことができる。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが好ましい。抽出時間は抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが好ましい。 As for yellow spirit, dried and pulverized one can be used as it is, but an extract extracted with a solvent or the like can also be used. At the time of extraction, it may be used as it is, but considering the extraction efficiency, it is desirable to perform the extraction after performing processing such as shredding, drying, and pulverization. The extraction can be performed by a general method such as a method of immersing in an extraction solvent or an extraction method using a supercritical fluid or the like. The extraction temperature is preferably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but is preferably about 1 hour to 14 days.
抽出溶媒としては、例えば、水、メタノール、エタノールのごとき低級アルコール、グリセリン、プロピレングリコール、1,3−ブチレングリコールなどの多価アルコール、酢酸エチル等のエステル類、アセトン等のケトン類、などの有機溶媒またはそれらの混合物を用いることができる。 Examples of the extraction solvent include organic compounds such as water, methanol, ethanol and other lower alcohols, glycerin, propylene glycol, polyhydric alcohols such as 1,3-butylene glycol, esters such as ethyl acetate, and ketones such as acetone. Solvents or mixtures thereof can be used.
得られた抽出物は、そのままでも用いることができるが、濃縮、乾固したものを水や溶媒に再度溶解したり、あるいはこれらの作用を損なわない範囲で脱色、脱臭、脱塩等の精製処理を行ったり、カラムクロマトグラフィーによる分画処理を行った後に用いてもよい。また、保存のため、精製処理の後凍結乾燥し、使用時に溶媒に溶解して用いることもできる。 The obtained extract can be used as it is, but the concentrated and dried product is dissolved again in water or a solvent, or purification treatment such as decolorization, deodorization, and desalting is performed without impairing these actions. Or after fractionation by column chromatography. For storage, it can be freeze-dried after purification and dissolved in a solvent when used.
本発明で用いる黄精抽出物の配合量は、液剤組成物全体の0.1w/w%以上であれば良いが、10w/w%を超える配合量では製剤時に気泡が発生するなどの弊害が生じやすくなる。よって、本発明で用いる黄精抽出物の配合量としてより好ましくは、0.1w/w%〜10w/w%が良い。 The blending amount of the yellow extract used in the present invention may be 0.1 w / w% or more of the whole liquid composition, but if the blending amount exceeds 10 w / w%, problems such as generation of bubbles at the time of preparation occur. It becomes easy. Therefore, the blending amount of the yellow extract used in the present invention is more preferably 0.1 w / w% to 10 w / w%.
本発明は、さらにその他生薬を配合することにより、さらなる効果を発揮することができる。 The present invention can exhibit further effects by further blending other herbal medicines.
本発明に用いることのできる生薬とは、好ましくは、菊花、高麗人参、茶、ガラナからなる群より選ばれる1種または2種以上である。 The herbal medicine that can be used in the present invention is preferably one or more selected from the group consisting of chrysanthemum, ginseng, tea, and guarana.
次に、本発明において用いるカフェインとは、医薬品用原料として市販されているものの他、飲食品用途として市販されている茶葉(Thea sinensis)やガラナ(Paullinia cupana)など、カフェインを多く含むことが知られている植物の抽出物を任意に用いることができる。 Next, the caffeine used in the present invention contains a lot of caffeine such as tea leaves ( Thea sinensis ) and guarana ( Paulinia cupana ) which are marketed as food and drink products, in addition to those marketed as raw materials for pharmaceuticals. An extract of a plant known in the art can be arbitrarily used.
本発明の液剤組成物には、通常液剤に用いることが可能な成分、例えば、ビタミン類、アミノ酸類、有機酸類、生薬、甘味料、香料、保存剤などの他、栄養強化成分、滋養強壮成分などを適時選択して配合することができ、液剤製造の常法により製造することができる。 In the liquid composition of the present invention, ingredients that can be used in normal liquid preparations, for example, vitamins, amino acids, organic acids, herbal medicines, sweeteners, fragrances, preservatives, etc., nutrition enhancing ingredients, nourishing tonic ingredients Etc. can be selected and blended in a timely manner, and can be produced by a conventional method for producing a liquid preparation.
以下に本発明の組成物のリラックス効果ならびに演算能力向上効果を、以下の調製例に示した飲料組成物ならびに実施例により確認した。なお、本発明はこれら実施例により何ら制限されるものではない
Below, the relaxation effect of the composition of this invention and the calculation capability improvement effect were confirmed by the drink composition and the Example which were shown to the following preparation examples. In addition, this invention is not restrict | limited at all by these Examples.
調製例:飲料組成物
被験飲料(各50mL)を表1に示す処方に従って調製した。各飲料はそれぞれ1試飲あたり、カフェイン150mg(比較例1)、黄精抽出物100mg(比較例2)、カフェイン150mgおよび黄精抽出物100mgを含有する(試験例1)。さらに、プラセボとして、カフェインと黄精抽出物のいずれをも含まないものを調製した(比較例3)。
Preparation Example: A beverage composition test beverage (each 50 mL) was prepared according to the formulation shown in Table 1. Each beverage contains 150 mg of caffeine (Comparative Example 1), 100 mg of yellow extract (Comparative Example 2), 150 mg of caffeine and 100 mg of yellow extract (Test Example 1). Furthermore, a placebo containing neither caffeine nor yellow extract was prepared (Comparative Example 3).
被験飲料ごとに、リラックス効果および演算能力向上効果についてテストした。 Each test beverage was tested for relaxation effect and computational performance improvement effect.
実施例1:脳波の計測
大脳の働きにともなって発生する脳波は、周波数と振幅によって4つのタイプに分類され、各脳波の出現頻度をもって脳の意識状態を計り知ることができる。周波数8〜13ヘルツのα波はリラックスや瞑想の意識状態を、周波数14〜30ヘルツのβ波は緊張状態を、周波数0.5〜3ヘルツのγ波は熟睡などの無意識状態を、周波数4〜7ヘルツのθ波はまどろみの意識状態を示す指標とされている。
Example 1: Measurement of brain waves The brain waves generated with the action of the cerebrum are classified into four types according to the frequency and amplitude, and the state of consciousness of the brain can be measured and known from the appearance frequency of each brain wave. An α wave with a frequency of 8 to 13 Hz indicates a conscious state of relaxation or meditation, a β wave with a frequency of 14 to 30 Hz indicates a tension state, a γ wave with a frequency of 0.5 to 3 Hz indicates an unconscious state such as deep sleep, and the frequency 4 A θ wave of ˜7 hertz is regarded as an index indicating a state of consciousness of stagnation.
テストは簡易脳波測定装置マインドナビ(日立超LSIシステムズ社製)を用いた。被験者の安静状態を保てる環境下にて、各飲料の飲用前後のα波出現頻度を記録し、その変化量をもって、飲用によるリラックス状態への誘導効果を評価した。結果を図1に示す。 For the test, a simple electroencephalogram measuring device Mind Navi (manufactured by Hitachi VLSI Systems) was used. In an environment where the subject was able to maintain a resting state, the frequency of appearance of α waves before and after the drinking of each beverage was recorded, and the amount of change was used to evaluate the effect of inducing relaxation by drinking. The results are shown in FIG.
図1に示したように、プラセボ(比較例3)と黄精抽出物のみを含む被験飲料(比較例2)では、飲用によるα波の出現頻度に明らかな変化は認められず、黄精抽出物のみでは、α波の増加をもたらさないことを示した。一方、カフェインを含む被験飲料(試験例1、比較例1)では飲用後のα波の増加、すなわち、脳意識レベルのリラックス状態への誘導効果が見られたが、とりわけカフェインと黄精抽出物の双方を含む被験飲料(試験例1)では当該効果の発現が顕著であり、黄精抽出物がカフェインのα波増強効果をよりいっそう強化すること示した。
As shown in FIG. 1, in the test beverage (Comparative Example 2) containing only the placebo (Comparative Example 3) and the yellow extract, no obvious change was observed in the frequency of appearance of α waves due to drinking, only the yellow extract Then, it showed that it does not bring about the increase of alpha wave. On the other hand, test drinks containing caffeine (Test Example 1 and Comparative Example 1) showed an increase in alpha waves after drinking, that is, an induction effect on a relaxed state of brain consciousness. In the test beverage containing both of the products (Test Example 1), the expression of the effect was remarkable, and it was shown that the extract of yellow spirit further enhances the α-wave enhancing effect of caffeine.
実施例2:演算能力の評価
演算能力は、一定時間内における百マス計算によって評価した。百マス計算とは、図2に示したように、縦と横に0〜9の10個ずつの数字が並べられた方眼様シートを用いて、10列×10行の足し算演算を行い、その結果を所定のマスに記入するというものである。なお、数字の並びは各シートごとに無作為に変化させたものを用いた。
Example 2: Evaluation of computing ability The computing ability was evaluated by calculating one hundred squares within a certain period of time. As shown in FIG. 2, the hundred-mass calculation is performed by adding 10 columns × 10 rows using a grid-like sheet in which 10 numbers of 0 to 9 are arranged vertically and horizontally. The result is entered in a predetermined square. In addition, the arrangement of numbers was changed randomly for each sheet.
被験者に被験飲料の飲用前後の各10分間に、可能な限りの百マス計算を行ってもらい、その回答数と正答率をもって、飲用による演算能力の向上効果を評価した。結果を図3と図4に示す。 The subject was asked to perform as many hundreds of calculations as possible during each 10 minutes before and after drinking the test beverage, and the improvement effect of the computing ability by drinking was evaluated with the number of answers and the correct answer rate. The results are shown in FIGS.
図3に示したように、プラセボ(比較例3)と黄精抽出物のみを含む被験飲料(比較例2)では、飲用による回答数の増加は認められず、黄精抽出物のみでは、回答数を増加させる作用がないことを示した。一方、カフェインを含む被験飲料(試験例1、比較例1)では、飲用による回答数の増加が認められた。とりわけカフェインと黄精抽出物の双方を含む被験飲料(試験例1)では、より顕著な回答数の増加が認められ、黄精抽出物がカフェインの飲用による回答数の増加作用をよりいっそう強化すること示した。 As shown in FIG. 3, in the test beverage (Comparative Example 2) containing only the placebo (Comparative Example 3) and the yellow extract, the increase in the number of responses due to drinking was not observed. It was shown that there was no effect to increase. On the other hand, in the test beverages containing caffeine (Test Example 1, Comparative Example 1), an increase in the number of responses due to drinking was observed. In particular, in the test drink containing both caffeine and yellow extract (Test Example 1), a more remarkable increase in the number of responses was observed, and the yellow extract further strengthened the effect of increasing the number of responses due to drinking caffeine. I showed that.
図4は正答率を示したものであるが、いずれの被験飲料の飲用でも正答率の低下は認められていない。すなわち、前記カフェインを含む被験飲料の飲用による回答数の増加は、単なる公知のカフェインの中枢性興奮作用によって誘発された、粗雑な回答数の増加ではなく、計算精度を損ねることなく、回答数を増したものであることを明らかにした。 FIG. 4 shows the correct answer rate, but no decrease in the correct answer rate is observed in any of the test beverages. That is, the increase in the number of responses by drinking the test beverage containing caffeine is not simply an increase in the number of rough responses induced by the known central excitatory action of caffeine, but without compromising calculation accuracy. Clarified that the number increased.
以上、カフェインの飲用は、脳の意識レベルを高度な思考活動を行う上での理想的なリラックス状態へと誘導し、あわせて効果的な演算能力の向上効果をもたらすが、その作用は、黄精抽出物との併用によってより、いっそう増強されることを見い出した。 As described above, drinking caffeine induces the brain's level of consciousness to an ideal relaxed state for advanced thinking activities, and at the same time, brings about an effect of improving effective computing ability. It was found that it was further enhanced by combined use with yellow extract.
本発明の経口用組成物を用いれば、優れた演算能力の向上効果を有する製剤を得ることができる。また、本発明の経口用組成物は、副作用等の心配がなく、日常的に連用可能な清涼飲料水やドリンク剤等として用いることができ、医薬品、医薬部外品、栄養補助食品、健康食品として利用することができる。
If the composition for oral use of this invention is used, the formulation which has the improvement effect of the outstanding computing ability can be obtained. Further, the oral composition of the present invention has no worries about side effects and can be used as a soft drink or drink that can be used on a daily basis, and can be used as a pharmaceutical, quasi-drug, dietary supplement, health food. Can be used as
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006243468A JP5010879B2 (en) | 2006-09-07 | 2006-09-07 | Liquid composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006243468A JP5010879B2 (en) | 2006-09-07 | 2006-09-07 | Liquid composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008063281A true JP2008063281A (en) | 2008-03-21 |
JP5010879B2 JP5010879B2 (en) | 2012-08-29 |
Family
ID=39286285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006243468A Active JP5010879B2 (en) | 2006-09-07 | 2006-09-07 | Liquid composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5010879B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001513509A (en) * | 1997-08-11 | 2001-09-04 | エル・ヴェ・エム・アッシュ ルシェルシュ | Use of Narcoli Lily Extract to Promote Dermal Elastin Synthesis |
JP2005176691A (en) * | 2003-12-18 | 2005-07-07 | Asahi Breweries Ltd | Nutritionally tonic alcoholic drink |
JP2006273809A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Vegetable trypsin inhibitor |
JP2007153816A (en) * | 2005-12-06 | 2007-06-21 | Taisho Pharmaceut Co Ltd | Fatigue relieving agent composition |
-
2006
- 2006-09-07 JP JP2006243468A patent/JP5010879B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001513509A (en) * | 1997-08-11 | 2001-09-04 | エル・ヴェ・エム・アッシュ ルシェルシュ | Use of Narcoli Lily Extract to Promote Dermal Elastin Synthesis |
JP2005176691A (en) * | 2003-12-18 | 2005-07-07 | Asahi Breweries Ltd | Nutritionally tonic alcoholic drink |
JP2006273809A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Vegetable trypsin inhibitor |
JP2007153816A (en) * | 2005-12-06 | 2007-06-21 | Taisho Pharmaceut Co Ltd | Fatigue relieving agent composition |
Also Published As
Publication number | Publication date |
---|---|
JP5010879B2 (en) | 2012-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dietz et al. | An intervention study on the effect of matcha tea, in drink and snack bar formats, on mood and cognitive performance | |
TWI500391B (en) | Composition for reliving and preventing hangover and beverage comprising composition | |
CN102293430A (en) | Beverage with functions of antioxidation and immunity enhancing, and preparation method thereof | |
KR101827326B1 (en) | Chinese medical composition for curing a hangover | |
JP2016538328A5 (en) | ||
CN104815100A (en) | Composition with effects of refreshing and restoring consciousness and application thereof | |
CN102813255B (en) | Functional health drink and preparation method thereof | |
JP5010879B2 (en) | Liquid composition | |
CN106176495B (en) | A kind of carefree shower cream and preparation method thereof | |
CN106266515B (en) | Join Siberian cocklebur grass composition, ginseng Siberian cocklebur grass drink and preparation method | |
CN114766565A (en) | Physical fatigue relieving tea beverage and preparation method thereof | |
JP2005239659A (en) | Precursor lipocyte differentiation inhibitor | |
CN110547381A (en) | Preparation method of papaya enzyme compound beverage | |
JP2011168523A (en) | Agent for alleviating symptom attributable to premenstrual syndrome and food and beverage containing the same | |
JP7383281B2 (en) | Oral composition and functional food for improving learning ability of young people | |
CN103070261B (en) | Formula of red bean tea powder and production method | |
JP2006348001A (en) | Poor circulation-improving agent and functional food | |
CN101569691B (en) | Refreshing pill and preparation method thereof | |
CN112516258B (en) | Composition, preparation method and application thereof | |
CN107467324A (en) | A kind of active component containing American cockroach has the coffee of anti-inflammation detumescence effect | |
RU2425583C1 (en) | "lofantovy" tea beverage | |
CN107712183A (en) | One group of U.S. face of enriching blood supports kidney rose-tee prescription | |
CN105875961A (en) | Lung moistening and phlegm eliminating healthy tea beverage | |
CN105232435A (en) | Rosemary essential oil bath salt and preparation method | |
CN106605879A (en) | Rosa roxburghii tratt fruit jam and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090528 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090528 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110927 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120214 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120403 |
|
RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20120403 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120403 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120522 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120604 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5010879 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150608 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |